XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Securities
9 Months Ended
Sep. 30, 2024
Securities [Abstract]  
Securities NOTE 3 – SECURITIES

The following tables summarize the amortized cost and fair value of the Company’s available-for-sale securities portfolio at September 30, 2024 and December 31, 2023 and the corresponding amounts of unrealized gains and losses recognized in accumulated other comprehensive loss:

Amortized Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value

September 30, 2024 (unaudited)

Corporate debt

$

9,982

$

-  

$

2,482

$

7,500

Issued by U.S. government-sponsored entities and agencies:

U.S. Treasury

1,189

1

-  

1,190

Total

$

11,171

$

1

$

2,482

$

8,690

Amortized Cost

Gross Unrealized Gains

Gross Unrealized Losses

Fair Value

December 31, 2023

Corporate debt

$

9,980

$

-  

$

2,880

$

7,100

Issued by U.S. government-sponsored entities and agencies:

U.S. Treasury

1,007

-  

19

988

Mortgage-backed securities - residential (1)

4

-  

-  

4

Total

$

10,991

$

-  

$

2,899

$

8,092

(1)Unrealized loss is less than $1 resulting in rounding to zero.

There was no impairment recognized in accumulated other comprehensive loss for securities available for sale at September 30, 2024 or September 30, 2023.

There were no sales of securities during the three and nine months ended September 30, 2024 and 2023.

The amortized cost and fair value of debt securities at September 30, 2024 and December 31, 2023 are shown in the table below by contractual maturity. Expected maturities may differ from contractual maturities if borrowers have the right to call or prepay obligations with or without call or prepayment penalties. Securities not due at a single maturity date are shown separately.

September 30, 2024

December 31, 2023

(unaudited)

Amortized Cost

Fair Value

Amortized Cost

Fair Value

Due in one year or less

$

1,189

$

1,190

$

1,007

$

988

Due from five to ten years

9,982

7,500

9,980

7,100

Mortgage-backed securities - residential

-  

-  

4

4

Total

$

11,171

$

8,690

$

10,991

$

8,092

Fair value of securities pledged as collateral was as follows:

September 30, 2024

December 31, 2023

(unaudited)

Pledged as collateral for:

FHLB advances

$

-  

$

497

Public deposits

645

492

Total

$

645

$

989

At September 30, 2024 and December 31, 2023, there were no holdings of securities of any one issuer in an amount greater than 10% of stockholders’ equity.

The following table summarizes securities with unrealized losses at September 30, 2024 and December 31, 2023, aggregated by major security type and length of time in a continuous unrealized loss position.

September 30, 2024 (unaudited)

Less than 12 Months

12 Months or More

Total

Description of Securities

Fair Value

Unrealized Loss

Fair Value

Unrealized Loss

Fair Value

Unrealized Loss

Corporate debt

$

-  

$

-  

$

7,500

$

2,482

$

7,500

$

2,482

Total impaired

$

-  

$

-  

$

7,500

$

2,482

$

7,500

$

2,482

December 31, 2023

Less than 12 Months

12 Months or More

Total

Description of Securities

Fair Value

Unrealized Loss

Fair Value

Unrealized Loss

Fair Value

Unrealized Loss

Corporate debt

$

-  

$

-  

$

7,100

$

2,880

$

7,100

$

2,880

Issued by U.S. government-sponsored entities and agencies:

U.S. Treasury

-  

-  

$

988

19

988

19

Mortgage-backed securities - residential (1)

1

-  

3

-  

4

-  

Total impaired

$

1

$

-  

$

8,091

$

2,899

$

8,092

$

2,899

(1)Unrealized loss is less than $1 resulting in rounding to zero.

At September 30, 2024, 86.3% of the Company’s available for sale securities were reported at less than historical cost. At December 31, 2023, 100% of the Company's available for sale securities were reported at less than historical cost.

The unrealized losses at September 30, 2024 were related to one Corporate debt security. The unrealized losses at December 31, 2023 were related to one Corporate debt security, one Mortgage-backed security and two U.S. Treasuries. Because the decline in fair value was attributable to changes in market conditions, and not credit quality, and because the Company did not have the intent to sell these securities and it was likely that it would not be required to sell these securities before their anticipated recovery, the Company did not record an allowance for credit losses at September 30, 2024 and December 31, 2023.